Metabolic remodelling of the failing heart: beneficial or detrimental? - Wikidata - awgldk - TriplyDB

Metabolic remodelling of the failing heart: beneficial or detrimental?

Metabolic remodelling of the failing heart: beneficial or detrimental?

http://www.wikidata.org/entity/Q37293624

about

Nutritional Deficiency in Patients with Heart Failure Quality control systems in cardiac aging DPP4 deficiency preserved cardiac function in abdominal aortic banding rats Effect of acute hyperglycemia on left ventricular contractile function in diabetic patients with and without heart failure: two randomized cross-over studies.Post-translational modifications of the cardiac proteome in diabetes and heart failure Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart: Implications for Cardiac Reloading and Conditioning ADP compartmentation analysis reveals coupling between pyruvate kinase and ATPases in heart muscle.Long-term effects of epoprostenol on the pulmonary vasculature in idiopathic pulmonary arterial hypertension.Increased expression of fatty-acid and calcium metabolism genes in failing human heart.Peroxisome proliferator-activated receptor (PPAR) gene profiling uncovers insulin-like growth factor-1 as a PPARalpha target gene in cardioprotection.Branched-chain amino acid metabolism in heart disease: an epiphenomenon or a real culprit?Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy.1H-NMR-based metabolic analysis of human serum reveals novel markers of myocardial energy expenditure in heart failure patients.Cardiomyopathy and Worsened Ischemic Heart Failure in SM22-α Cre-Mediated Neuropilin-1 Null Mice: Dysregulation of PGC1α and Mitochondrial Homeostasis.Pressure overload-induced mild cardiac hypertrophy reduces left ventricular transmural differences in mitochondrial respiratory chain activity and increases oxidative stress.Activated protein C modulates cardiac metabolism and augments autophagy in the ischemic heart.E2F6 Impairs Glycolysis and Activates BDH1 Expression Prior to Dilated Cardiomyopathy Carnitine palmitoyltransferase-1b deficiency aggravates pressure overload-induced cardiac hypertrophy caused by lipotoxicity Catabolic Defect of Branched-Chain Amino Acids Promotes Heart Failure Testosterone Replacement Modulates Cardiac Metabolic Remodeling after Myocardial Infarction by Upregulating PPARα.Metabolic gene remodeling and mitochondrial dysfunction in failing right ventricular hypertrophy secondary to pulmonary arterial hypertension.Mesenchymal stem cell transplantation for the infarcted heart: therapeutic potential for insulin resistance beyond the heart.Increased mean aliphatic lipid chain length in left ventricular hypertrophy secondary to arterial hypertension: A cross-sectional study.Alterations in mitochondrial function as a harbinger of cardiomyopathy: lessons from the dystrophic heart.Energetics and metabolism in the failing heart: important but poorly understood.Up-regulation of the cardiac lipid metabolism at the onset of heart failure.Mitochondrial protein phosphorylation as a regulatory modality: implications for mitochondrial dysfunction in heart failure.Endoplasmic reticulum and the unfolded protein response: dynamics and metabolic integration Metabolic remodeling in chronic heart failure.Remodeling and dedifferentiation of adult cardiomyocytes during disease and regeneration.Heart failure and loss of metabolic control Fatty acids and cardiac disease: fuel carrying a message.Myocardial energetics and ubiquinol in diastolic heart failure.Hexokinases and cardioprotection.It is BEAUTIFUL we should be concerned about, not SIGNIFY: is ivabradine less effective in ischaemic compared with non-ischaemic LVSD?Role of Pleiotropic Properties of Peroxisome Proliferator-Activated Receptors in the Heart: Focus on the Nonmetabolic Effects in Cardiac Protection.β-adrenergic receptor signalling and its functional consequences in the diseased heart.Metabolic support for the heart: complementary therapy for heart failure?A comprehensive review of the bioenergetics of fatty acid and glucose metabolism in the healthy and failing heart in nondiabetic condition.Expression of lipogenic genes is upregulated in the heart with exercise training-induced but not pressure overload-induced left ventricular hypertrophy.

P2860

Q26741764-4E1D76D5-ADA8-4D38-A6AA-2C56E1938F4E Q28084341-7E5BAD05-E198-4694-AFDC-BE0C8A4D6C5B Q28538591-2FCA042D-CD9A-4973-89BA-8B069C1D30F4 Q30459207-1D0AA87B-3C76-4BB1-9FA4-95A0EA812594 Q33361067-242C1AB8-BDD0-4E31-B4D2-87443C944F87 Q33651722-6C022C1A-3B72-437E-B938-D66B30DA67FF Q33908355-3D92EB7C-100E-46E9-802A-879C903AA470 Q34275313-15FAEF07-8798-4CFB-A272-122AE2F24AA0 Q34305150-DC5C0B66-9715-4F83-B57B-BE9AD1CE401B Q34800455-51AC9168-5C97-4052-9D58-C8598B56E136 Q34808547-F3A1C122-5707-4AB7-BF7F-DCAEAD5CA17F Q35045900-A2E41933-A6FA-407C-9F1D-E27F71F17A7C Q35088508-B5199CB8-0333-4C3E-819B-DAA00D9FEF34 Q35637897-5FB81A41-E2E6-4CA1-888D-28B33667F7FB Q36193631-5F994EA1-3B51-48EB-BBEE-990E6C36374B Q36207893-23960774-21FC-40A5-9E1B-480FCA38D588 Q36248883-475BD5E1-3931-4B86-8FBF-A252656FF793 Q36359620-823A0842-9E8D-43A9-9B28-8564475452DF Q36932534-34B1144C-546E-4B76-82AC-DE84013C4EC2 Q37054050-02593CCE-9EA1-42F2-B2C0-6AB15D2E93EB Q37216215-1EA96297-A2F0-409F-95F8-A8669B97976E Q37357426-D6E4CF78-B346-49C5-B643-78D3D0B3E760 Q37432845-183382DE-A7AB-49BB-B7BB-6948BAD9E2A5 Q37601041-5ECADDED-2FCE-4F4C-A5FA-84744736A937 Q37746834-5564253D-F202-4667-AA0C-D006AABAAFAB Q37895302-BD88892E-E61C-43DC-A4E3-BED723A185E6 Q37959068-3F43A2C7-6ABD-4C80-B204-6355D44E5162 Q38073952-43FBD7FE-26D4-4BBA-ABE0-E661F44AC95A Q38125159-615C636D-323F-4103-9EE3-754DCC515796 Q38169962-2C3A2012-51CE-4D06-A5E9-30ACF0AB2854 Q38171215-88602F06-04FA-47B5-985F-ACD516780824 Q38207743-5D6E6B1A-6E10-4573-AC06-819A7AA64EE4 Q38255039-2AE6DB83-EC02-4E6E-A54D-D6EA225C2416 Q38255143-053EB5DA-C15B-4FB5-9231-8C000DCEBD32 Q38494523-2207D213-DBCA-4BBC-8D52-C1FA46E15C7F Q38640842-3FEA0FED-A249-4D74-9D87-C4E17468733E Q38722030-D5F18A51-07AD-4A7E-9712-EB56ECB56F8A Q38998576-4AE45469-9685-490C-B355-552BAF1A154E Q39325799-C211C603-AC6A-4817-BE34-71129ED3307B Q39427371-60556E0B-2B06-4113-98DF-632F2E60A938

P2860

Metabolic remodelling of the failing heart: beneficial or detrimental?

http://www.wikidata.org/entity/Q37293624

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 14 October 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Metabolic remodelling of the failing heart: beneficial or detrimental?

@en

Metabolic remodelling of the failing heart: beneficial or detrimental?

@nl

type

label

Metabolic remodelling of the failing heart: beneficial or detrimental?

@en

Metabolic remodelling of the failing heart: beneficial or detrimental?

@nl

prefLabel

Metabolic remodelling of the failing heart: beneficial or detrimental?

@en

Metabolic remodelling of the failing heart: beneficial or detrimental?

@nl

P1433

Q37293624-C992F4A4-8368-4901-B794-85A1A0407DC1

P1476

Q37293624-A8EA22DA-4C4D-42D6-ACCB-AD1B2EA456D0

P2093

Q37293624-1FD53397-2625-4188-9D2B-908A3D9E9C13

Q37293624-4C9221E8-C102-45E3-BF45-9AA761EEFF8B

Q37293624-552FCF1C-1031-46FF-BF69-45AEE7AE7995

P2860

Q37293624-0676A8EC-AF9D-4DFA-BB4A-5348F8637B85

Q37293624-12BBDDB9-366E-47C3-844E-EC504D00AF03

Q37293624-1446CE2F-C4AF-41CD-B539-F313F9769544

Q37293624-15145213-0DF9-4C53-9F40-298FC6826084

Q37293624-1699FDD8-E529-46B4-BA6C-7D08763F59E4

Q37293624-17E2ED5A-D67C-4F5C-96EB-1B030B02B427

Q37293624-22F22B1C-4BD6-4523-9048-0B12F0F667E6

Q37293624-277357EF-5DB4-4679-8B5E-B1FC66AFEA78

Q37293624-28EE498C-E596-4624-89AF-1A5860F055F7

Q37293624-2A761EEF-1CE3-48EF-B5CD-FA65AD171F88

P304

Q37293624-A48ABB5C-5690-4706-8A3F-A7BE3633A96E

P31

Q37293624-27720519-91F1-4FB1-826D-9F751CA3DF92

P356

Q37293624-498A1BDE-6420-4771-A1DA-310BAA5B3196

P433

Q37293624-8CF3E4EF-A649-4F9E-9C40-723BF219306A

P478

Q37293624-85256B2D-D95F-4FED-B120-739B234A00F0

P577

Q37293624-46C5333D-9513-403C-8491-F6070274B157

P5875

Q37293624-5E7E6E6A-C0FD-4555-979B-E991AA684DDC

P698

Q37293624-47131F1C-0E65-4C66-9A81-6BB2A5E191AE

P356

P1433

Cardiovascular Research

P1476

Metabolic remodelling of the failing heart: beneficial or detrimental?

@en

P2093

Frans A van Nieuwenhoven

http://www.w3.org/2001/XMLSchema#string

Ger J van der Vusse

http://www.w3.org/2001/XMLSchema#string

Marc van Bilsen

http://www.w3.org/2001/XMLSchema#string

P2860

Downregulation of metabolic gene expression in failing human heart before and after mechanical unloading

Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart

Peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta/delta, but not PPARgamma, modulate the expression of genes involved in cardiac lipid metabolism

The failing heart--an engine out of fuel

Metabolic cardiomyopathies.

A randomized clinical trial of trimetazidine, a partial free fatty acid oxidation inhibitor, in patients with heart failure.

The use of partial fatty acid oxidation inhibitors for metabolic therapy of angina pectoris and heart failure.

Energy metabolism in heart failure.

Metabolic remodelling of the failing heart: the cardiac burn-out syndrome?

Altered creatine kinase adenosine triphosphate kinetics in failing hypertrophied human myocardium.

P304

420-428

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVN282

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

81

http://www.w3.org/2001/XMLSchema#string

P577

2008-10-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23318804

http://www.w3.org/2001/XMLSchema#string

P698

18854380

http://www.w3.org/2001/XMLSchema#string